ClinicalTrials.govpublic full text
The Multicentre Selective Lymphadenectomy Trial - 3
cutaneous melanoma, stage iii, neoadjuvant, non-inferiority, randomised controlled trial, adverse events, quality of life, healthcare economics, index lymph node resection, therapeutic lymph node dissection, surgical morbidity, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 978871
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.